Literature DB >> 12856149

Fatal, gold-induced pneumonitis.

M Jose Soler1, Encarnacion Barroso, F Ignacio Aranda, Sergio Alonso, Santiago Romero.   

Abstract

We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12856149     DOI： 10.1007/s00296-003-0293-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   3.580


  16 in total

1.  Serious opportunistic infection associated with gold-induced panhypogammaglobulinaemia.

Authors:  T M Lawson; M Bevan; S Linton; B D Williams
Journal:  Br J Rheumatol       Date:  1998-08

2.  Gold pneumonitis. A case report with electronmicroscopy and electron probe analysis.

Authors:  Y Lertratanakul; E Budiman-Mak; A A Dietz; V R Jablokow; S Rothfuss; H R Schumacher
Journal:  Clin Exp Rheumatol       Date:  1986 Oct-Dec       Impact factor: 4.473

3.  Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis.

Authors:  M R Shaban; D N Golding; R G Letcher
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

4.  Fatal bronchiolitis obliterans associated with chrysotherapy.

Authors:  L Holness; J Tenenbaum; N B Cooter; R F Grossman
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

5.  Pulmonary gold toxicity.

Authors:  T F Morley; H J Komansky; R A Adelizzi; J C Giudice
Journal:  Eur J Respir Dis       Date:  1984-11

6.  Chrysotherapy. Suppression of immunoglobulin synthesis.

Authors:  A Lorber; T Simon; J Leeb; A Peter; S Wilcox
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

7.  Hypoxemic respiratory failure in rheumatoid arthritis: gold related?

Authors:  T W Noseworthy; R S Davey; J S Percy; E G King
Journal:  Crit Care Med       Date:  1983-09       Impact factor: 7.598

8.  Gold-induced pneumonitis.

Authors:  R Slingerland; H C Hoogsteden; H J Adriaansen; T H van der Kwast; C Hilvering
Journal:  Respiration       Date:  1987       Impact factor: 3.580

9.  Diffuse pulmonary injury associated with gold treatment.

Authors:  R H Winterbauer; K R Wilske; R F Wheelis
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

10.  Pneumonitis caused by gold salt therapy: evidence for the role of cell-mediated immunity in its pathogenesis.

Authors:  J McCormick; S Cole; B Lahirir; F Knauft; S Cohen; T Yoshida
Journal:  Am Rev Respir Dis       Date:  1980-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.